Contract Reserach

Fusion of Technologies Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan.

The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies

Products with Status Development

ProductCASSpecificationStatus
Everolimus9003-97-8In-houseDevelopment
Caspofungin Acetate179463-17-3In-houseDevelopment
Eletriptan HBr177834-92-3In-houseDevelopment
Temsirolimus162635-04-3In-houseDevelopment

Products with Status Investigation

ProductCASSpecificationStatus
Micafungin Sodium208538-73-2In-houseInvestigation
Anidulafungin166663-25-8In-houseInvestigation
Zotarolimus221877-54-9In-houseInvestigation
Biolimus851536-75-9In-houseInvestigation